Helius Medical Technologies, Inc.
HSDT
$4.18
-$0.24-5.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.29% | -6.57% | -128.66% | 35.93% | -140.77% |
| Total Depreciation and Amortization | -33.33% | -25.00% | 0.00% | 0.00% | -23.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.52% | 22.18% | 186.23% | -162.55% | 36.01% |
| Change in Net Operating Assets | -171.15% | 276.87% | -79.27% | -110.26% | 86.46% |
| Cash from Operations | -48.70% | 14.18% | 4.15% | 3.67% | -47.54% |
| Capital Expenditure | -- | -- | -- | 100.00% | -66.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -66.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -99.94% | 3.39% | 135.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -103.70% | 5,650.68% | -151.72% |
| Cash from Financing | -- | 100.00% | -102.64% | 285.51% | 135.21% |
| Foreign Exchange rate Adjustments | -- | -300.00% | -- | 100.00% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.88% | 18.47% | -206.18% | 278.04% | -9.19% |